Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Authors’ response to letter to editor—silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis (2026) Atreya R, Neurath M Journal article Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review (2026) Vieujean S, Atreya R, Buda A, Caradec J, Citi S, Danese S, Dewit O, et al. Journal article, Review article Definitions, diagnosis, management, and outcomes of upper gastrointestinal Crohn's disease: an international, expert RAND/UCLA appropriateness study (2026) Cohen NA, Bettenworth D, Sror N, Khedraki R, Yang Q, Abreu MT, Atreya R, et al. Journal article, Review article Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease (2026) Reinisch W, Atreya R, Rieder F, Jairath V, Rimola J, Peyrin-Biroulet L, Tozer P, et al. Journal article, Review article Intestinal barrier healing is superior to transmural healing to prevent disease progression in clinical remittent patients with inflammatory bowel disease (2026) Orlemann T, Zimmermann D, Hübner H, Atreya R, Bodenschatz J, Noviello D, Vitali F, et al. Journal article Filamin a binds deleted in liver cancer 1 (DLC1) to promote its tumor suppressor activity and inhibit the SRF coactivator MRTF-A (2026) Sergeev M, Meier M, Wohlleben P, Rupprecht L, Kupraszewicz-Hutzler M, Hilgers KF, Hartner A, et al. Journal article Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis (2026) Atreya R, Neurath M Journal article JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease (2025) Fousekis FS, Jefremow A, Katsanos KH, Neurath M, Atreya R Journal article, Review article Resolving Loss of Response to Ustekinumab in Crohn’s Disease: POWER Through or Switch Treatment? (2025) Noviello D, Atreya R, Noor NM Journal article An international consensus on the design of clinical trials for advanced combination treatment (ACT) in inflammatory bowel disease (2025) Solitano V, Hanžel J, Ma C, Battat R, Raine T, Siegmund B, Peyrin-Biroulet L, et al. Journal article